Refine
Year of publication
Language
- English (44)
- German (2)
- Portuguese (1)
Has Fulltext
- yes (47)
Is part of the Bibliography
- no (47)
Keywords
- Head and neck cancer (3)
- Radiotherapy (3)
- Biomarker (2)
- Breast cancer (2)
- Fasting (2)
- Glioblastoma (2)
- Glucose (2)
- HNSCC (2)
- Ketogenic diet (2)
- Leptin (2)
- Postoperative radiochemotherapy (2)
- Radiation (2)
- Rectal cancer (2)
- composite structures (2)
- head and neck squamous cell carcinoma (2)
- ACLF (1)
- ALL (1)
- AML (1)
- Acute myeloid leukemia (1)
- Addison’s disease (1)
- All-trans retinoic acid (1)
- Alveolar macrophages (1)
- Anakinra (1)
- Antiretroviral therapy (1)
- Antisemitismus (1)
- Back pain (1)
- Bevacizumab (1)
- Bladder cancer (1)
- Bone metastases (1)
- Brasilien (1)
- Business strategy in drug development (1)
- COVID (1)
- CUP (1)
- CXCR4 (1)
- Cancer of unknown primary (1)
- Capecitabine (1)
- Cardiac output (1)
- Caro, Herbert Moritz (1)
- Central nervous system metastases (1)
- Cervical (1)
- Checkpoint inhibitor (1)
- Chemical company (1)
- Chemoradiotherapy (1)
- Cross-sectional study (1)
- Culture positive (1)
- DKTK-ROG (1)
- De-isolation (1)
- Diagnostic differentiation (1)
- Disabling back pain (1)
- Drug therapy (1)
- Echocardiography (1)
- Exil (1)
- Fibroblast (1)
- First site of metastatic disease (1)
- Gadobutrol (1)
- Gadopentate dimeglumine (1)
- Genetics research (1)
- Germany (1)
- Guided waves (1)
- Guidelines (1)
- HIV (1)
- HPV (1)
- Hemodynamic management (1)
- Hsp70 (1)
- IHC (1)
- Immunotherapy (1)
- Influenza (1)
- Interleukin-1 (1)
- Jude (1)
- Liposomes (1)
- Locally advanced (1)
- Loco-regional control (1)
- Lymph node (1)
- MLL (1)
- MRI (1)
- Machine learning (1)
- Multinomial logistic regression (1)
- Mycobacteria (1)
- Mycobacterium avium complex (1)
- NAFL (1)
- NASH (1)
- NK cells (1)
- Nanomedicine (1)
- Nek1 (1)
- Nivolumab (1)
- Noninferiority (1)
- Nontuberculous mycobacteria (1)
- Nucleophosmin-1 (1)
- Occupational medicine (1)
- Open pulmonary tuberculosis (1)
- Opportunistic infections (1)
- Oxaliplatin (1)
- PD-1 inhibitor (1)
- Parainfluenza (1)
- Patterns of care (1)
- Pneumonia (1)
- Predictive markers (1)
- Preoperative radiochemotherapy (1)
- Prevalence (1)
- Prevention (1)
- Prognostic (1)
- Protease inhibitor therapy (1)
- Pulse contour analysis (1)
- Pulse pressure variation (1)
- Radical cystectomy (1)
- Radiomics (1)
- Renal lesions (1)
- Respiratory infections (1)
- Respiratory syncytial virus (1)
- SCCHN (1)
- SDF-1 (1)
- SPSS (1)
- Salivary gland carcinoma (1)
- Sputum smear-negative (1)
- Stroke volume variation (1)
- Superinfection (1)
- Surgery (1)
- Surgical oncology (1)
- TB-therapy (1)
- TGFB-induced factor homeobox 1 (1)
- TGIF (1)
- Targeted drug delivery (1)
- Thermodilution (1)
- Transitional cell carcinoma (1)
- Treatment protocol (1)
- Tuberculosis (1)
- Upper respiratory tract infection (1)
- Urothelial cancer (1)
- Validation (1)
- accident (1)
- acute decompensation (1)
- acute leukemia (1)
- acute-on-chronic liver failure (1)
- adrenal insuffciency (1)
- adult (1)
- basal cell carcinoma (1)
- bevacizumab (1)
- cerebral radiation necrosis (1)
- cerebrospinal fluid (1)
- cervical cancer (1)
- chemotherapy (1)
- chromosomal translocations (1)
- cirrhosis (1)
- clinical trial (1)
- colorectal cancer (1)
- computed tomography (1)
- diffusion-weighted magnetic resonance imaging (1)
- discontinuous dose dependency (1)
- dysbiosis (1)
- fractionation (1)
- gene signature (1)
- hedgehog signaling pathway (1)
- hepatic encephalopathy (1)
- image-based risk modelling (1)
- immune modulation (1)
- inflammation (1)
- injury (1)
- liver (1)
- lockdown (1)
- low-dose radiation therapy (1)
- machine learning (1)
- magnetic resonance imaging (1)
- medulloblastoma (1)
- microbiome (1)
- multiplexed immunofluorescence (1)
- neoadjuvant chemoradiotherapy (1)
- omega stringer (1)
- open guided waves (1)
- oral cavity cancer (1)
- p16 (1)
- p53 (1)
- pediatric intensive care (1)
- personalised therapy (1)
- phase I (1)
- portal hypertension (1)
- portosystemic shunt (1)
- postoperative radiochemotherapy (1)
- postoperative radiotherapy (1)
- predictive biomarker (1)
- prognostic biomarker (1)
- prognostic marker (1)
- propensity score matching (1)
- radiation oncology (1)
- radiomic (1)
- radiosensitization (1)
- radiotherapy (1)
- radiotherapy resistance (1)
- randomized (1)
- reference damage (1)
- retrospective trial (1)
- scanning laser Doppler vibrometry (1)
- signal processing (1)
- spontaneous portosystemic shunt (1)
- structural health monitoring (1)
- subgrouping (1)
- targeted therapy (1)
- translocation partner genes (1)
- trauma (1)
- vismodegib (GDC-0449) (1)
- xenograft (1)
- Übersetzer (1)
Institute
- Medizin (38)
- Physik (3)
- Biochemie und Chemie (1)
- Biowissenschaften (1)
- Georg-Speyer-Haus (1)
- Informatik (1)
- Mathematik (1)
- Universitätsbibliothek (1)
The KASCADE-Grande experiment has significantly contributed to the current knowledge about the energy spectrum and composition of cosmic rays for energies between the knee and the ankle. Meanwhile, post-LHC versions of the hadronic interaction models are available and used to interpret the entire data set of KASCADE-Grande. In addition, a new, combined analysis of both arrays, KASCADE and Grande, was developed significantly increasing the accuracy of the shower observables. First results of the new analysis with the entire data set of the KASCADE-Grande experiment will be the focus of this contribution.
Highlights
• Open pulmonary tuberculosis patient discharge policy was not reviewed for decades.
• After smear-negativity conversion, substantial cultural positivity may remain.
• It remains unclear, whether smear-negative patients still may be infective.
• The clinical relevance of this finding warrants further investigation.
Abstract
Objectives: Patients with open pulmonary tuberculosis (opTB) are subject to strict isolation rules. Sputum smear microscopy is used to determine infectivity, but sensitivity is lower than for culture. This study aimed to investigate the clinical relevance of this mismatch in contemporary settings.
Methods: Differential results between microscopy and culture were determined at the time of microscopic sputum conversion, from all patients with opTB between 01/2013 and 12/2017. In addition, data on HIV, multi/extensive drug-resistant TB status, time to smear- and cultural-negativity conversion were analyzed; and a Kaplan-Meier curve was developed.
Results: Of 118 patients with opTB, 58 had demographic data available for microbiological and clinical follow-up analysis; among these, 26 (44.8%) had still at least one positive culture result. Median time from opTB-treatment initiation to full microscopic sputum- or culture conversion, was 16.5 days (range 2-105), and 20 days (1-105), respectively (median difference: +3.5 days). Sixteen days after de-isolation, >90% had converted culturally. HIV- or multi/extensive drug-resistant TB status did not impact conversion time.
Conclusion: When patients with opTB were de-isolated after 3 negative sputum smear microscopy tests, a substantial part still revealed cultural growth of Mycobacterium tuberculosis complex, but it remains unclear, whether smear-negative and culturally-positive individuals on therapy are really infective. Thus, the clinical relevance of this finding warrants further investigation.
Comprehensive analysis of tumour sub-volumes for radiomic risk modelling in locally advanced HNSCC
(2020)
Simple Summary: Radiomic risk models are usually based on imaging features, which are extracted from the entire gross tumour volume (GTV entire ). This approach does not explicitly consider the complex biological structure of the tumours. Therefore, in this retrospective study, we investigated the prognostic value of radiomic analyses based on different tumour sub-volumes using computed tomography imaging of patients with locally advanced head and neck squamous cell carcinoma who were treated with primary radio-chemotherapy. The GTV entire was cropped by different margins to define the rim and corresponding core sub-volumes of the tumour. Furthermore, the best performing tumour rim sub-volume was extended into surrounding tissue with different margins. As a result, the models based on the 5 mm tumour rim and on the 3 mm extended rim sub-volume showed an improved performance compared to models based on the corresponding tumour core. This indicates that the consideration of tumour sub-volumes may help to improve radiomic risk models.
Abstract: Imaging features for radiomic analyses are commonly calculated from the entire gross tumour volume (GTVentire). However, tumours are biologically complex and the consideration of different tumour regions in radiomic models may lead to an improved outcome prediction. Therefore, we investigated the prognostic value of radiomic analyses based on different tumour sub-volumes using computed tomography imaging of patients with locally advanced head and neck squamous cell carcinoma. The GTVentire was cropped by different margins to define the rim and the corresponding core sub-volumes of the tumour. Subsequently, the best performing tumour rim sub-volume was extended into surrounding tissue with different margins. Radiomic risk models were developed and validated using a retrospective cohort consisting of 291 patients in one of the six Partner Sites of the German Cancer Consortium Radiation Oncology Group treated between 2005 and 2013. The validation concordance index (C-index) averaged over all applied learning algorithms and feature selection methods using the GTVentire achieved a moderate prognostic performance for loco-regional tumour control (C-index: 0.61 ± 0.04 (mean ± std)). The models based on the 5 mm tumour rim and on the 3 mm extended rim sub-volume showed higher median performances (C-index: 0.65 ± 0.02 and 0.64 ± 0.05, respectively), while models based on the corresponding tumour core volumes performed less (C-index: 0.59 ± 0.01). The difference in C-index between the 5 mm tumour rim and the corresponding core volume showed a statistical trend (p = 0.10). After additional prospective validation, the consideration of tumour sub-volumes may be a promising way to improve prognostic radiomic risk models.
Purpose: To develop and validate a CT-based radiomics signature for the prognosis of loco-regional tumour control (LRC) in patients with locally advanced head and neck squamous cell carcinoma (HNSCC) treated by primary radiochemotherapy (RCTx) based on retrospective data from 6 partner sites of the German Cancer Consortium - Radiation Oncology Group (DKTK-ROG).
Material and methods: Pre-treatment CT images of 318 patients with locally advanced HNSCC were collected. Four-hundred forty-six features were extracted from each primary tumour volume and then filtered through stability analysis and clustering. First, a baseline signature was developed from demographic and tumour-associated clinical parameters. This signature was then supplemented by CT imaging features. A final signature was derived using repeated 3-fold cross-validation on the discovery cohort. Performance in external validation was assessed by the concordance index (C-Index). Furthermore, calibration and patient stratification in groups with low and high risk for loco-regional recurrence were analysed.
Results: For the clinical baseline signature, only the primary tumour volume was selected. The final signature combined the tumour volume with two independent radiomics features. It achieved moderately good discriminatory performance (C-Index [95% confidence interval]: 0.66 [0.55–0.75]) on the validation cohort along with significant patient stratification (p = 0.005) and good calibration.
Conclusion: We identified and validated a clinical-radiomics signature for LRC of locally advanced HNSCC using a multi-centric retrospective dataset. Prospective validation will be performed on the primary cohort of the HNprädBio trial of the DKTK-ROG once follow-up is completed.
Background and Aim: Several studies observed alterations in the gut microbiota in patients with non‐alcoholic fatty liver disease (NAFLD). However, analyzed patient populations and methods strongly differ among these studies. The aim of this study was to prove the reproducibility of published results and to provide a detailed overview of all findings in our NAFLD cohort using next generation sequencing methods.
Methods: The individual taxonomic microbiota composition of fecal samples from 90 NAFLD patients and 21 healthy controls was analyzed using 16S rRNA gene sequencing. Study participants were grouped according to their disease stage and compared regarding their gut microbiota composition. Studies were identified from PubMed listed publications, and the results were compared with the findings in our cohort.
Results: Results from 13 identified studies were compared with our data. A decreased abundance of the Bacteroidetes and Ruminococcaceae as well as an increased abundance of Lactobacillaceae and Veillonellaceae and Dorea were the most frequently reported changes among NAFLD patients in 4/13, 5/13, 4/13, 2/13, and 3/13 studies, respectively. Even though these alterations in the gut microbiota composition were also observed in our patient cohort, the majority of published differences could not be reproduced, neither in our own nor in other NAFLD cohort studies.
Conclusion: Despite repeatedly reproduced abundance patterns of specific bacteria, the heterogeneous study results did not reveal a consistent disease specific gut microbiota signature. Further prospective studies with homogenous patient cohorts and standardized methods are necessary to phenotype NAFLD by the gut microbiota.
The third dataset dedicated to the Open Guided Waves platform aims at carbon fiber composite plates with an additional omega stringer at constant temperature conditions. The two structures used in this work are representative for real aircraft components. Comprehensive measurements were recorded in order to study (I) the impact of the omega stringer on guided wave propagation, and (II) elliptical reference damages of different sizes located at three separate positions on the structure. Measurements were recorded for narrowband excitation (5-cycle toneburst with varying carrier frequencies) and broadband excitation (using chirp waveforms). The paper presents the results of a technical validation including numerical modelling, and enables further research, for example related to probability of detection (POD) analysis.
Ultrasonic guided waves have been used successfully in structural health monitoring systems to detect damage in isotropic and composite materials with simple and complex geometry. A limitation of current research is given by a lack of freely available benchmark measurements to comparatively evaluate existing methods. This article introduces the extendable online platform Open Guided Waves (http://www.open-guided-waves.de) where high-quality and well-documented datasets for guided wave-based inspections are provided. In this article, we describe quasi-isotropic carbon-fiber-reinforced polymer plates with embedded piezoelectric transducers as a first benchmark structure. Intentionally, this is a structure of medium complexity to enable many researchers to apply their methods. In a first step, ultrasound and X-ray measurements were acquired to verify pristine conditions. Next, mechanical testing was done to determine the stiffness tensor and sample density based on standard test procedures. Guided wave measurements were divided into two parts: first, acoustic wave fields were acquired for a broad range of frequencies by three-dimensional scanning laser Doppler vibrometry. Second, structural health monitoring measurements in the carbon-fiber-reinforced polymer plate were collected at constant temperature using a distributed transducer network and a surface-mounted reversible defect model. Initial results serving as validation are presented and discussed.